MIRA Pharmaceuticals (MIRA) Institutional Ownership $1.21 +0.01 (+0.83%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for MIRA Pharmaceuticals (NASDAQ:MIRA)CurrentInstitutional OwnershipPercentage35.16%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$642.73KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$22.75K Get MIRA Insider Trade Alerts Want to know when executives and insiders are buying or selling MIRA Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MIRA Institutional Buying and Selling by Quarter MIRA Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/8/2025 International Assets Investment Management LLC25,000$29K0.0%N/A0.151% 10/23/2024Cross Staff Investments Inc365,901$476K0.4%-4.6%2.475% 10/21/2024Suncoast Equity Management90,000$117K0.0%+125.0%0.609% 5/20/2024Virtu Financial LLC63,055$69K0.0%+330.2%0.427% 5/2/2024Suncoast Equity Management40,000$44K0.0%N/A0.271% 5/2/2024Cross Staff Investments Inc383,401$422K0.4%N/A2.594% 4/10/2024 Praetorian Wealth Management Inc.27,500$30K0.0%N/A0.186% (Data available from 1/1/2016 forward) MIRA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MIRA shares? During the previous two years, the following institutional investors and hedge funds held shares of MIRA Pharmaceuticals shares: Cross Staff Investments Inc ($476K), Suncoast Equity Management ($117K), Virtu Financial LLC ($69K), and Praetorian Wealth Management Inc. ($30K), International Assets Investment Management LLC ($29K).Learn more on MIRA's institutional investors. What percentage of MIRA Pharmaceuticals stock is owned by institutional investors? 35.16% of MIRA Pharmaceuticals stock is owned by institutional investors. Learn more on MIRA's institutional investor holdings. Which institutional investors have been buying MIRA Pharmaceuticals stock? The following institutional investors have purchased MIRA Pharmaceuticals stock in the last 24 months: Cross Staff Investments Inc ($383.40K), Suncoast Equity Management ($90K), Virtu Financial LLC ($48.40K), Praetorian Wealth Management Inc. ($27.50K), and International Assets Investment Management LLC ($25K). How much institutional buying is happening at MIRA Pharmaceuticals? Institutional investors have bought a total of 574,298 shares in the last 24 months. This purchase volume represents approximately $642.73K in transactions. Which MIRA Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold MIRA Pharmaceuticals stock in the last 24 months: Cross Staff Investments Inc ($17.50K). How much institutional selling is happening at MIRA Pharmaceuticals? Institutional investors have sold a total of 17,500 shares in the last 24 months. This volume of shares sold represents approximately $22.75K in transactions. Related Companies ESSA Pharma Institutional Ownership Assertio Institutional Ownership Theratechnologies Institutional Ownership Aadi Bioscience Institutional Ownership Context Therapeutics Institutional Ownership Quince Therapeutics Institutional Ownership InterCure Institutional Ownership Mersana Therapeutics Institutional Ownership Ikena Oncology Institutional Ownership Adlai Nortye Institutional Ownership This page (NASDAQ:MIRA) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MIRA Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MIRA Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.